| Jul 29 |
Viatris 2023 Sustainability Report: Empowering Healthcare Workers
|
| Jul 26 |
3 Surprisingly Underrated Stocks to Buy Right Now
|
| Jul 23 |
Viatris 2023 Sustainability Report: Building Access Through a Global and Flexible Supply Chain
|
| Jul 21 |
Warner Bros. Discovery & Coinbase Are Among 10 Large Cap Stocks That Shined Most Last Week (July 14-July 20): Are The Others In Your Portfolio?
|
| Jul 18 |
Viatris 2023 Sustainability Report: Our Strategy and Model for Sustainable Access to Medicine
|
| Jul 17 |
Big pharma rally after J&J earnings
|
| Jul 10 |
3 Generic Drug Stocks to Watch Amid Improving Market Prospects
|
| Jul 4 |
Viatris closes $3.37bn divestitures with OTC deal
|
| Jul 3 |
Viatris Brings to Completion All Previously Announced Divestitures With the Closing of its Over-the-Counter Business Divestiture
|
| Jul 2 |
Viatris’ Mylan no longer subject of DOJ drug price-fixing probe
|
